GALA RENEE D 4

What Happened
Gala Renee D, a director of DexCom, Inc. (DXCM), was granted 5,605 restricted stock units (RSUs) on May 28, 2026. The award was reported on a Form 4 filed June 1, 2026. The RSUs were granted at $0.00 (no cash exchanged) and each RSU represents a contingent right to receive one share of DexCom common stock upon settlement.

Key Details

• Transaction date: 2026-05-28 (Grant / Award, code A) — 5,605 RSUs @ $0.00 (value $0 reported)
• Vesting: 100% of the May 28, 2026 RSU award vests on the earlier of the one-year anniversary of the grant or DexCom's 2027 Annual Meeting of Stockholders (Footnote F1).
• Holdings noted: Footnote F2 indicates 9,418 unvested RSUs are included in the reported holdings — 5,605 from this grant and 3,813 from a March 6, 2025 grant that vest through March 6, 2028.
• Filing: Form 4 filed 2026-06-01 for a 2026-05-28 transaction — this appears to be filed after the typical two-business-day reporting window.
• Exhibit: Exhibit 24 (Power of Attorney) included with the filing.

Context
RSUs are a form of equity compensation that convert into shares when they vest and are settled; they do not indicate an immediate purchase or sale. Grants to directors are common as part of compensation and do not by themselves signal a buy/sell decision. This transaction is an award/grant (not a sale), so it is generally treated as routine compensation rather than a direct market signal.